2026 ASCO Breast Cancer Highlights: Neo-Healer

Harold Burstein, MD, PhD, and Adrienne Waks, MD discuss the new Neo-Healer trial in HER2+ breast cancer.

October 15, 2026

Dana-Farber

Objective:

Harold Burstein, MD, PhD, and Adrienne Waks, MD, discuss the Neo-Healer trial in HER2-positive breast cancer.

Interpretation:

The supplied material identifies the speakers and topic but provides no discussion details or trial findings.

Limitations:

No transcript details or study results were provided.

Original Source(s)

Dana-Farber

2026 ASCO Breast Cancer Highlights: Neo-Healer

October 15, 2026

Related Content

Dana-Farber

2026 ASCO Breast Cancer Highlights: PANKU-Breast02

Harold Burstein, MD, PhD, and Ana C. Garrido-Castro, MD discuss new results from the PANKU-Breast02 Study on a new dual-antibody drug conjugate, called izalontamab brengitecan (iza-bren), for metastatic triple-negative breast cancer.

October 15, 2026
1 min

Dana-Farber

2026 ASCO Breast Cancer Highlights: HER2CLIMB-05

Harold Burstein, MD, PhD, and Adrienne Waks, MD discuss the HER2Climb-05 trial and how it impacts treatment for HER2+ metastatic breast cancer

October 15, 2026
1 min

The Analytical Scientist

A Glimpse into the Future of Analytical Instrument Design?

Michael John Fanous’s portable scanner uses AI to reconstruct images blurred by continuous high-speed acquisition

by Helen Bristow, James Strachan
October 7, 2026
7 min